中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US08475790B2 Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases 有权
CD137抗体与CTLA-4抗体的组合用于治疗增殖性疾病

  • Patent Title: Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases
  • Patent Title (中): CD137抗体与CTLA-4抗体的组合用于治疗增殖性疾病
  • Application No.: US13122630
    Application Date: 2009-10-05
  • Publication No.: US08475790B2
    Publication Date: 2013-07-02
  • Inventor: Maria Jure-Kunkel
  • Applicant: Maria Jure-Kunkel
  • Applicant Address: US NJ Princeton
  • Assignee: Bristol-Myers Squibb Company
  • Current Assignee: Bristol-Myers Squibb Company
  • Current Assignee Address: US NJ Princeton
  • Agent Stephen C. D'Amico
  • International Application: PCT/US2009/059518 WO 20091005
  • International Announcement: WO2010/042433 WO 20100415
  • Main IPC: A61K39/395
  • IPC: A61K39/395
Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases
Abstract:
Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders.
Abstract(Chinese):

公开了可用于治疗和预防增殖性疾病的组合物和方法。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0